Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Foundations of High-Value Discovery Deals

May 01 2002

Related Content

In Context: Aventis-Genta after Bristol-ImClone

May 01 2002

Playing the High-Stakes Pharma Game, Part I

Sep 01 1999

Selling Structure

Mar 01 2001

ArQule Takes the Drug Discovery Plunge

Jun 01 2001

Related Companies

Pfizer Inc.

ArQule, Inc.

Discovery Partners International Inc.

Tripos, Inc.

ChemBridge Corp.

Incyte Corporation

Exelixis, Inc.

Bristol Myers Squibb Company

Entelos Inc.

Takeda Pharmaceutical Co. Ltd.

Cubist Pharmaceuticals, Inc.

Pfizer Inc.

Affinium Pharmaceuticals, Ltd.

Onyx Pharmaceuticals, Inc.

Vertex Pharmaceuticals Incorporated

Takeda Pharmaceutical Co. Ltd.

Monsanto Company

Evotec SE

Neurogen

Sanofi

Cytokinetics, Inc.

Johnson & Johnson

Schering-Plough

Merck & Co., Inc.

PDL BioPharma, Inc.

GSK plc

CuraGen Corporation

Bayer AG

Genta, Inc.

Eli Lilly and Company

Taisho Pharmaceutical Co., Ltd.

Kyowa Kirin Co., Ltd.

Additional Topics

Strategy Business Strategies Platform Technologies BioPharmaceutical

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window